ARTBIO secures $90m to advance alpha radioligand therapies pipeline

By NS Healthcare Staff Writer

08 Dec 23

The funding will be used to solidify the firm’s AlphaDirect technology, which is a Pb212 isolation method, and…

PharmaceuticalsDrug discovery

AQEMIA, Sanofi ink $140m research collaboration deal for small molecules

By NS Healthcare Staff Writer

06 Dec 23

Under the terms of this arrangement, the French pharmatech firm will use its deep physics and generative AI…

PharmaceuticalsDrug discovery

Odyssey Therapeutics Announces $101 Million Series C Financing

By NS Healthcare Staff Writer

06 Dec 23

Financing led by Ascenta Capital with participation from new and existing investors; Dr. Lorence Kim joins board of…

PharmaceuticalsDrug discovery

Absci, AstraZeneca partner to develop AI-based oncology candidate

By NS Healthcare Staff Writer

05 Dec 23

The partnership combines AstraZeneca's expertise in oncology R&D with Absci's Integrated Drug Creation platform to expedite the discovery…

PharmaceuticalsDrug discovery

Seismic Therapeutic raises $121m to advance ML-optimised immunology pipeline

By NS Healthcare Staff Writer

05 Dec 23

The proceeds from the funding round will be used by the company to advance the Phase 1 proof-of-mechanism…

PharmaceuticalsDrug discovery

AWS, Amgen partner on generative AI solutions for advanced therapies

By NS Healthcare Staff Writer

29 Nov 23

AWS will help Amgen discover, develop, and boost the production throughput of medicines and increase sustainability and operational…

PharmaceuticalsDrug discovery

PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target

By NS Healthcare Staff Writer

29 Nov 23

Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics technology

PharmaceuticalsDrug discovery

Boehringer Ingelheim, IBM partner to expedite antibody discovery

By NS Healthcare Staff Writer

28 Nov 23

Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…

PharmaceuticalsDrug discovery

Genethon Using Artificial Intelligence to Improve Effectiveness of Gene Therapies and Patient Access

By NS Healthcare Staff Writer

28 Nov 23

CEO Frederic Revah discusses how Artificial Intelligence is creating next-generation gene therapy vectors and reducing bioproduction costs in…

PharmaceuticalsDrug discovery

Vivodyne raises $38m to develop lab-grown human organs for drug testing

By NS Healthcare Staff Writer

23 Nov 23

The company has designed an AI stack to detect new therapeutic targets and forecast responses of patients to…

PharmaceuticalsDrug discovery